Receive our newsletter – data, insights and analysis delivered to you
  1. News
November 20, 2019

Baring Private Equity Asia signs agreement to buy Lumenis

Baring Private Equity Asia’s (BPEA) affiliated private equity funds have signed an agreement to buy Lumenis, a provider of speciality energy-based medical devices.

Baring Private Equity Asia’s (BPEA) affiliated private equity funds have signed an agreement to buy Lumenis, a provider of speciality energy-based medical devices.

The deal takes enterprise value of Lumenis to more than $1bn.

Lumenis provides minimally invasive clinical solutions for aesthetic, surgical and ophthalmology specialities.

It has been operating in the field for more than five decades and has around 1,500 employees across its global operations.

It has a presence in more than 100 countries, with Asia Pacific region being its largest market.

Lumenis CEO Tzipi Ozer-Armon said: “BPEA’s investment is a tremendous vote of confidence in Lumenis and in the achievements of our entire global organisation. In recent years, we have developed and introduced multiple groundbreaking technological solutions that have redefined our industry and opened entirely new market segments.

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

“I would like to thank the entire Lumenis team, I am truly proud of all we have accomplished and honoured to lead a company on the cutting edge of healthcare innovation, committed to improving the lives of people across the world.

“We look forward to partnering with the team at BPEA to continue developing and delivering to the world better technology for better patient care.”

BPEA managing director Yan Jiao said: “Lumenis has built a market-leading position by creating some of the most innovative technologies in the industry. It is a clear leader worldwide, especially in Asia which recently emerged as the largest market for medical and aesthetic treatments.

“We look forward to working with the CEO and management team to support their global growth aspirations.”

Subject to the customary regulatory approvals, the deal is expected to complete in early 2020.

Baring Private Equity Asia has a total committed capital of more than $18bn.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU